Augmentation of paroxetine with clocapramine in panic disorder.
Saito
Masanori
M
Miyaoka
Hitoshi
H
D000328:Adult; D017109:Akathisia, Drug-Induced / Q000523:psychology; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use*; D003984:Dibenzazepines / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D016584:Panic Disorder / Q000188:drug therapy* / Q000523:psychology; D017374:Paroxetine / Q000009:adverse effects / Q000627:therapeutic use*
D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D000697:Central Nervous System Stimulants; D003984:Dibenzazepines; D017374:Paroxetine; C000449:3-chlorocarpipramine